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Abstract
Typically, the categorization of odontogenic cysts is complex and can cause a dilemma 
equally for specialists as well as pathologists. The odontogenic keratocyst (OKC) is 
defi nitely a developmental cyst, which is worthy of special consideration. It possesses 
typical histopathological as well as clinical attributes; however, the thing that makes 
this particular cyst unique is defi nitely its overly aggressive tendencies and also a high 
recurrence rate. In spite of several classes and nomenclature, sadly the specialists 
nevertheless have to encounter challenges in the control over this frequently observed 
jaw lesion. This particular brief article is an attempt to deliver a breakdown of numerous 
facets of OKC with focus on recurrence and the need for a perfect treatment of 
keratocystic odontogenic tumor.
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Introduction
Originally coined by Philipsen (1956),[1] odontogenic 
keratocyst (OKC) is actually a developmental cyst. OKC is 
currently referenced by the World Health Organization (WHO) 
as being a keratocystic odontogenic tumor (KCOT), and WHO 
outlined it as “a noncancerous uni-or multi-cystic, intraosseous 
tumor of odontogenic origin, having a typical inner lining 
of parakeratinized stratifi ed squamous epithelium as well as 
likelihood of a potent, destructive behavior.[2] KCOT is amongst 
the most unpredictable odontogenic cysts. It may grow to be 
fairly massive as a result of its capability for sizeable enlargement, 
extension into surrounding structures, as well as speedy increase 
in size.[3] Various reports revealed the frequency of KCOT being 
3-11% of the odontogenic cysts.[4] Usually, KCOT tend to be 
individual lesions except if they may be linked to nevoid basal 
cell carcinoma syndrome.[4]
KCOT develops out of the cell rests of the dental lamina.[5] 
Histopathologically, KCOT ordinarily exhibits a slender, friable 
wall structure, and this can be challenging to enucleate from 
the bone fragment successfully as a whole, and possess tiny 
satellite cysts inside the fi brous wall structure. As a result, 
OKCs frequently have a tendency to be recurrent following 
management.[6] Radiographically, KCOT displays a well-defi ned 
unilocular or multilocular radiolucency together with even as well 
as typically corticated edges. In 25-40% of occasions, it comes 
with an impacted tooth within the lesion. KCOT are inclined 
to expand in the anteroposterior direction inside the medullary 
cavity of the bone without resulting in apparent enlargement 
leading to its late observation by the aﬀ ected individuals.[6,7]
Typically, the management of KCOT is still debatable. 
The treatment modalities can be conservative or aggressive. 
Conventional management usually comprises of simple 
enucleation, together with or without the curettage, or 
marsupialization. Aggressive management commonly entails 
peripheral ostectomy, chemical curettage with Carnoy’s 
solution, cryotherapy, or electrocautery and resection.[8,9] 
The line of therapy needs to be determined by numerous 
variables; affected individuals age, overall size and site of 
the cyst, involvement of soft tissue, record regarding prior 
management as well as a histological variation of the disease. 
The actual objective would be to select a treatment method 
that bears the minimum likelihood of recurrence and the 
slightest morbidity.[10]
Decompression and Marsupialization
Decompression of a cyst consists of pretty much any procedure, 
which minimizes the stress inside the cyst because this 
pressure may be the means through which the cyst expands. 
Decompression can be done by developing a little opening 
within the cyst plus maintaining it open with a drain.[2,11]
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Marsupialization, however, entails transforming the cyst to a 
sack and so the cyst is actually decompressed, nevertheless this 
is a far more conclusive treatment than decompression since 
it exposes the cyst walls to the oral environment. Mandibular 
cysts are typically marsupialized within the oral cavity, whereas 
maxillary cysts might also be marsupialized inside the maxillary 
sinus or nasal cavity, in addition to the oral cavity.[2,12]
Decompression and marsupialization of cysts is most likely 
the foremost suggested remedy and had been primarily proposed 
by Partsch in the later part of the 19th century. In several regions 
of the globe, marsupialization continues to be referred to as 
a Partsch I technique (the Partsch II procedure is enucleation 
and primary closure).[13] Despite the fact that decompression or 
marsupialization had not been advised as cure for KCOT by a 
few experts, since it had been believed that the pathologic tissue 
could be remaining in situ[14] decompression or marsupialization 
continues to be encouraged in many reports as being a technique 
that enables subtle reduction in size in the KCOT in order that 
important structures like teeth or the inferior alveolar nerve may 
be preserved.[15,16]
Those writers who happen to be opposed to the usage of 
marsupialization or decompression to treat KCOT rely on, the fact 
that this approach fails to eliminate entirely the complete cystic 
coating, which will result in a continuation of epithelial proliferation 
and promote the recurrence.[17] A recurrence rate of 25% has 
been documented in 32 cases when decompression was used as 
the sole treatment.[6] However, additional research indicates that 
the marsupialization of KCOT may be associated with complete 
settlement of the lesion with virtually no further surgery.[11,16]
The actual marsupialization method was explained by Pogrel in 
which a window of a minimum of one centimeter across is created 
into a cyst, as well as an eﬀ ort is made to suture the cyst lining to 
the oral mucosa. Within the maxilla, the cyst is then simply just 
often loaded with packing protruding through the opening. The 
fi lling contains iodoform gauze heavy-laden with the bacitracin 
cream. After it is taken out from the maxilla, the cavity is typically 
self-maintaining and the aﬀ ected individual would need to irrigate 
2 times a day to avoid food deposition or closure of the fi stula. In 
the mandible, there exists a higher inclination for natural closure 
of the fi stula and reformation of the cyst, especially in the posterior 
mandible. In these instances, we have realized that the utilization 
of a nasopharyngeal anesthesia tube suitably trim down makes an 
exceptional stent to help keep the cyst amenable. Once more, the 
cavity is irrigated 2 times a day.[16]
Research has proven that if the KCOT is opened up to the 
oral cavity through marsupialization, several modifi cations 
happen in the cyst lining. Histologically, the lining of KCOT 
is just Five to six cells deep and also breaks quickly upon 
attempted enucleation; and that is one of the many factors 
behind the high recurrence rate. With decompression or 
marsupialization, the lining seems to end up denser and simpler 
to enucleate, and histologically it can seem to modify and appear 
like typical oral mucosa, both with routine histology together 
with immunohistochemistry.[16] Pogrel fi nally stated that, 
decompression and/or marsupialization is as good a treatment 
modality as any other aggressive one as it has a low morbidity 
rate, and no vital structures are harmed.
Enucleation With and Without Adjuncts
To enucleate is simply “to clear away as a whole, the tumor from 
its envelope.” Curettage means “the eradication of abnormal 
growths or any other content out of the wall of the cavity.[18] 
Enucleation together with and without diﬀ erent adjuncts has 
long been employed. Despite the fact that enucleation/curettage 
provides the edge over marsupialization of providing an entire 
sample for histopathologic evaluation, it displays recurrence 
rates as excessive as 62.5%, which can be no more a satisfactory 
treatment form. This signifi cant likelihood of recurrence is 
actually revealed from the slender, friable wall structure of 
the KCOT, that is hard to enucleate from the bone fragments 
successfully, as well as the tiny satellite cysts inside of the fi brous 
wall.[11,12] A lot of specialists take into account enucleation and 
curettage as the bare minimum prerequisite in the management 
of KCOT.[19] Concerning curettage, clinicians currently have 
recommended mechanized methods (hand, rotary) alone or 
perhaps in conjunction with a compound solution (Carnoy’s)[20] 
or cryosurgical products (liquid nitrogen).[21]
Enucleation and Treatment of the Bony Defect with 
Carnoy Solution
As a consequence of the problem regarding enucleating the 
slender, friable wall structure of the KCOT as a whole, in addition 
to the little satellite cysts, thus, treatment method ought to attempt 
to remove the possible critical cells left out in the defect. For this 
particular purpose a gentle, not profoundly infi ltrating, cauterizing 
agent is employed for example Carnoy’s solution (is made up 
3 ml of chloroform, 6 ml of absolute ethanol, One milliliter of 
glacial acetic acid as well as One g of ferric chloride).[22] This is 
generally suﬃ  cient to complete cauterization of the leftover cells. 
Should the cyst have permeated via the lingual or buccal cortex, 
surgeons referred to the employment of electrocauterization in 
order to avoid a recurrence within the soft tissues.[23]
Additional research demonstrated that, even though the 
problem appeared to be cured with Carnoy’s solution, Microcysts 
as well as epithelial islands ended up generally in the overlying 
attached mucosa. Therefore, recurrence occurred. Thus, the 
particular writers of all of these scientifi c studies suggested 
the total removal of the overlying mucosa to diminish the 
recurrence.[20] Additionally it was cited in a research the fact that 
treatment with Carnoy’s solution failed to display a substantial 
association with recurrence.[9] Yet, Voorsmit et al. documented a 
reduced recurrence rate subsequent to therapy using enucleation 
along with Carnoy’s solution (2.5%) in contrast with enucleation 
on its own (13.5%).[22]
As per (Blanas et al., 2000) enucleation of KCOT and use 
of Carnoy’s solution seems to be the most minimally invasive 
procedure together with the smallest recurrence rate. Plus they 
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documented that incorporating Carnoy’s solution to the cyst 
cavity for 3 min following enucleation provides a recurrence rate 
similar to those of resection without the need of unjustifi able 
aggressive surgery.[24]
The side eﬀ ects associated with Carnoy’s solution over 
the inferior alveolar nerve had been initially reported by 
Frerich et al. (1994).[25] The writers failed to detect axonal 
injury through the initial 3 min of the primary application. 
On the other hand, another signifi cant research, Wright et 
al. (1981)[26] mentioned how the modifi cations in neural 
conductivity established soon after 2 min of immediate 
application, with hardly any indications of healing following 
2 weeks of follow-up. Nonetheless, Dammer et al. (1997),[27] 
claimed that whenever a suitable standard protocol is adopted, 
the chemical therapy for the nerve can be achieved devoid of 
long lasting functional deterioration.
Enucleation and Liquid Nitrogen Cryotherapy
In principle, the optimal strategy for KCOT will be enucleation 
as well as curettage accompanied by treating the cavity using an 
agent designed to destroy the epithelial remains or satellite cysts. 
Furthermore, the osseous structure ought to be kept undamaged 
to enable osteoconduction. Liquefi ed nitrogen has the capacity to 
devitalize bone in situ whilst rendering the inorganic framework 
unchanged, as a consequence of this, cryotherapy has been 
employed for several locally potent jaw lesions, such as KCOT, 
ameloblastoma and ossifying fi broma (Pogrel, 1993, Lo Muzio 
1999).[28,29] Cell death by using cryosurgery takes place simply 
by immediate injury from intra cellular as well as extracellular 
ice crystal development in addition to osmotic and electrolyte 
disturbances (Rosen and Vered, 1979).[30]
As per Pogrel (2001)[21] the regular method is as follows, 
the 1st step in treating of the lesion is enucleation of the cyst. 
The encompassing tissues are after that guarded with clean 
and sterile wooden tongue blades as well as gauze, and also the 
cavity is applied with liquid nitrogen 2 times for 1 min, using a 
5 min thaw in between freezes. Bone graft may load within the 
defect all at once, after which mucosa is closed up with water 
tight sutures.
The attributes of liquid nitrogen above other methods of 
devitalizing the tissue over and above the noticeable lesion of the 
border are that (1) the actual bone fragments matrix remains in 
position to act like a clear scaﬀ old for new bone development, 
(2) a bone graft may be put instantly in order to speed up 
healing and reduce the chance of a pathologic bone fracture, and 
(3) reduction in hemorrhage and scarring. Nevertheless, due to 
the issues in managing the quantity of liquid nitrogen used on 
the cavity, the resulting necrosis in addition to swelling might 
be erratic (Pogrel, 1993; Salmassy and Pogrel, 1995).[29,31] The 
recurrence rate subsequent to enucleation and liquid nitrogen 
cryotherapy happens to be documented at 3-9% (Pogrel, 2005; 
Schmidt, 1999).[16,21]
Any time the liquid nitrogen cryotherapy is administered 
about the inferior alveolar nerve, it can be damaged, and aﬀ ected 
individuals are aﬀ ected by paresthesia or maybe anesthesia. Even 
so, the axon sheaths are still undamaged and neural regrowth is 
typical in a way that most patients acquire incomplete or total 
return of senzation in 3 months (Schmidt, 1999).[21]
Block Resection, With or Without Preservation of the 
Continuity of the Jaw
Resection represents possibly segmental resection (surgery 
associated with a portion of the mandible or maxilla without 
preserving the continuity of the bone) or marginal resection 
(surgery of a lesion undamaged, having a rim of uninvolved 
bone, retaining the continuity of the bone) (Kondell and Wiberg, 
1988)[32] which inturn is a risky approach, that ends up in 
signifi cant morbidity, specially due to the fact that reconstructive 
procedures are required to bring back jaw functionality as well 
as aesthetics (Barreto et al. 2000)[33] Jensen (1988),[34] ponders 
whether or not this kind of ambitious treatments are justifi ed 
for a benign lesion that can be managed reasonably well with 
relatively simple means.
In a thorough overview by Blanas et al. (2000),[24] the 
particular experts documented that resection was identifi ed 
to provide the least recurrence rate (0%) however it has the 
maximum morbidity rate, whereas enucleation with use of 
Carnoy’s solution can lead to a recurrence rate similar to 
resection without unjustifi able aggressive surgery.
Numerous research determined that keratocysts may be 
addressed with a conservative approach, the sole drawbacks 
being the prolonged curative time frame.[27,35-37] Substantial 
resection of the mandible having a high morbidity might be way 
too radical for massive KCOT and perhaps an overtreatment 
(Giuliani et al., 2006; Marker et al., 1996).[38,39]
Summary
KCOT is amongst the numerous overly aggressive odontogenic 
cysts having a signifi cant recurrence rate. Numerous surgical 
strategies have been published such as decompression, 
marsupialization, enucleation with or without adjunct (Carnoy’s 
solution, cryotherapy), as well as resection. Based on additional 
scientifi c studies KCOT may be cautiously addressed with 
enucleation and use of Carnoy’s solution or cryotherapy. This 
kind of treatment can be utilized mainly in the sizeable lesions 
that in case cured with resection, the continuity of the jaw would 
be disrupted. This method displays very similar outcomes to 
other more aggressive methods.
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